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Background: Verbal Autopsy (VA) is widely viewed as the only immediate strategy for registering cause of death in
much of Africa and Asia, where routine physician certification of deaths is not widely practiced. VA involves a lay
interview with family or friends after a death, to record essential details of the circumstances. These data can then
be processed automatically to arrive at standardized cause of death information.
Methods: The Population Health Metrics Research Consortium (PHMRC) undertook a study at six tertiary hospitals
in low- and middle-income countries which documented over 12,000 deaths clinically and subsequently undertook
VA interviews. This dataset, now in the public domain, was compared with the WHO 2012 VA standard and the
InterVA-4 interpretative model.
Results: The PHMRC data covered 70% of the WHO 2012 VA input indicators, and categorized cause of death
according to PHMRC definitions. After eliminating some problematic or incomplete records, 11,984 VAs were
compared. Some of the PHMRC cause definitions, such as ‘preterm delivery’, differed substantially from the
International Classification of Diseases, version 10 equivalent. There were some appreciable inconsistencies between
the hospital and VA data, including 20% of the hospital maternal deaths being described as non-pregnant in the
VA data. A high proportion of VA cases (66%) reported respiratory symptoms, but only 18% of assigned hospital
causes were respiratory-related. Despite these issues, the concordance correlation coefficient between hospital and
InterVA-4 cause of death categories was 0.61.
Conclusions: The PHMRC dataset is a valuable reference source for VA methods, but has to be interpreted with
care. Inherently inconsistent cases should not be included when using these data to build other VA models.
Conversely, models built from these data should be independently evaluated. It is important to distinguish between
the internal and external validity of VA models. The effects of using tertiary hospital data, rather than the more
usual application of VA to all-community deaths, are hard to evaluate. However, it would still be of value for VA
method development to have further studies of population-based post-mortem examinations.
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Verbal Autopsy (VA, the practice of interviewing witnesses
of a death and processing the information into likely causes
of death) is recognized as an important strategy for widen-
ing the scope of cause-specific mortality data, particularly
in countries where most deaths pass unregistered and
unattended by medical professionals. There has been
considerable development in recent years of automated
procedures for systematically coding VA data into cause of
death outcomes, which are seen as a necessary strategy to
underpin widespread, rapid and cost-effective approaches
to registering cause of death [1].
Inevitably, one of the major challenges to developing
fit-for-purpose VA interpretative models is capturing the
necessary knowledge in a valid and usable manner. Some
models have sought to be entirely based on data, including
in some cases the application of machine learning tech-
niques to construct the model’s evidence base [2,3]. Others
have developed systematic approaches to incorporating
human medical expertise as the basis of model building
[4]. In both cases, there is also an obvious desire to be
able to test models with high-quality VA data in order to
demonstrate validity in terms of relationships between the
input side (VA interview material) and the output side
(cause of death assignment) [5,6].
To meet this need, the Population Health Metrics
Research Consortium (PHMRC) undertook a data collec-
tion exercise between 2007 and 2010 in four countries
(India, Mexico, Tanzania and the Philippines) which
documented 12,542 deaths in high-level hospitals where
excellent diagnostic facilities were available during final
illnesses, and then followed up the deaths with VA inter-
views [7]. This dataset was dubbed as ‘gold standard’ VA
data in findings published in 2011. In October 2013 the
dataset was released into the public domain, and this
dataset is examined here in terms of its compatibility
with the WHO 2012 VA standard [8,9], its completeness
and quality, and consistency between the hospital cause
of death categorization and the InterVA-4 model (which
is exactly compatible with the WHO 2012 VA standard)
[10]. The objectives in undertaking these analyses are to
arrive at a better understanding of how useful the PHMRC
dataset might be for developing general VA methods and
to explore the external validity of the dataset.
Methods
The PHMRC public-domain dataset [11] contains tertiary
hospital assignments of cause of death and responses to
subsequent VA interviews. The data are divided into three
sections according to variations in the VA instrument used
for the neonatal period (including stillbirths), childhood
(one month to eleven years) and adulthood (twelve years
and older). Two separate sites were covered in India (Andra
Pradesh and Uttar Pradesh) and Tanzania (Dar es Salaamand Pemba island), with one each in the Philippines (Bohol)
and Mexico (Mexico City). The public domain dataset
contains slightly fewer cases than were originally reported
(12,530 versus 12,542). An overall summary of the data is
presented in Table 1 by site, age group and cause of death
according to the hospital diagnosis. No hospital data other
than the cause of death category are available in the dataset,
and the cause categories were pre-defined as previously
described [7].
The VAs that were subsequently performed on the
PHMRC hospital deaths used a set of standard forms
covering each of the three age groups, yielding databases
with structures defined in a spreadsheet [12]. In addition,
the original VAs contained an open narrative section which
is not available in the public domain dataset, but the dataset
does include some machine-extracted variables indicating
the presence of certain key words within those narratives.
However, in the present analyses it was not possible to
make use of those key word variables because no clear
distinction was made between narratives containing, for
example, the word ‘heartbeat’ in the phrases ‘the baby’s
heartbeat was normal’ or ‘the baby had no heartbeat’.
The WHO 2012 VA standard [8] and InterVA-4 [10]
define 244 yes/no indicators covering VAs relating to
various age and sex groups. A correspondence table between
the WHO 2012 indicators and the PHMRC database is
available in Additional file 1. Overall 170/244 (69.7%) of
the WHO indicators were available in the PHMRC data-
set, and these variables were extracted into a dataset for
processing using the InterVA-4 model (version 4.02) [13].
Some problems were encountered in the age and sex vari-
ables in the PHMRC dataset. Dates of birth and death were
recorded in two duplicate sets of variables (g1_01/6 and
g5_01/3) as well as duplicate variables for age at death
(g1_07 and g5_04). For some individuals there were in-
consistencies between these age-related variables, and
cases were dropped where these inconsistencies resulted
in ambiguities between WHO 2012 age groups. Overall,
494 cases (3.9%) in the PHMRC dataset had no valid age
or sex recorded and were excluded from InterVA-4 pro-
cessing. A further 36 cases (0.3%) reported none of the
WHO 2012 symptom indicators and were likewise ex-
cluded. Analyses of InterVA-4 outputs are, therefore,
based on 11,984 cases.
The InterVA-4 model requires estimates of HIV/AIDS
and malaria levels among deaths in what would normally
be a population (rather than a group of hospital cases),
as described in the User Guide [14]. In the PHMRC study,
there was no intention that the deaths recorded were in
any way representative of local populations, and so these
parameters were set according to the overall levels of
HIV/AIDS and malaria according to the hospital causes
of death. In Andhra Pradesh, Dar es Salaam and Uttar
Pradesh malaria levels were high (>1% of all deaths)
Table 1 Summary of PHMRC VA dataset for 12,530 deaths by cause of death, age group (adult, child and neonate) and site
Site Andhra Pradesh Bohol Dar es Salaam Mexico City Pemba Uttar Pradesh Total
Cause of death category Ad Ch Ne Ad Ch Ne Ad Ch Ne Ad Ch Ne Ad Ch Ne Ad Ch Ne
AIDS 136 1 203 19 120 43 522
Acute myocardial infarction 101 116 3 76 104 400
Asthma 21 6 12 1 6 1 47
Birth asphyxia 115 50 134 45 66 52 462
Bite of venomous animal 31 33 1 1 33 21 120
Breast cancer 3 28 90 69 5 195
COPD 25 4 2 63 77 171
Cervical cancer 3 9 108 31 4 155
Cirrhosis 51 39 27 133 63 313
Colorectal cancer 7 24 33 35 99
Congenital malformation 63 41 62 61 19 3 249
Diabetes 88 77 59 105 38 47 414
Diarrhea/dysentery 77 35 27 22 37 50 18 8 21 64 48 77 484
Drowning 32 29 4 9 13 4 28 6 33 31 189
Encephalitis 7 34 41
Epilepsy 30 5 6 2 5 48
Esophageal cancer 1 5 34 40
Falls 32 12 38 6 11 1 36 2 26 4 30 24 222
Fires 35 30 7 25 15 18 1 6 7 31 15 190
Hemorrhagic fever 30 13 1 7 51
Homicide 31 35 30 37 3 31 167
Leukemia/lymphomas 7 15 59 72 3 156
Lung cancer 5 23 11 59 8 106
Malaria 29 12 34 102 2 2 35 216
Maternal 71 41 135 39 46 136 468
Measles 1 22 23
Meningitis 6 2 23 27 58
Meningitis/sepsis 2 19 132 7 1 5 166
Other cancers 7 8 2 3 8 28
Other cardiovascular diseases 76 14 78 12 112 32 81 7 69 11 492
Other defined causes of
child deaths
31 20 31 48 30 34 194
Other digestive diseases 5 18 9 13 3 48
Other infectious diseases 34 4 51 9 37 9 37 6 3 2 101 37 330
Other injuries 31 7 23 2 3 37 103
Other non-communicable
diseases
90 125 171 122 54 37 599
Pneumonia 55 102 7 142 124 18 95 111 43 102 22 41 134 2 105 39 13 1155
Poisonings 30 3 3 3 8 2 9 1 1 35 9 104
Preterm delivery 85 90 244 127 53 61 660
Prostate cancer 1 4 32 11 48
Renal failure 102 68 49 92 105 416
Road traffic 39 33 55 3 31 15 34 2 11 8 32 31 294
Sepsis 29 21 32 10 46 138
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Table 1 Summary of PHMRC VA dataset for 12,530 deaths by cause of death, age group (adult, child and neonate) and site
(Continued)
Stillbirth 102 156 435 75 119 118 1005
Stomach cancer 5 5 21 31 62
Stroke 125 179 103 122 101 630
Suicide 49 16 13 11 2 33 124
TB 101 22 103 17 6 27 276
Violent death 26 26 52
ALL CAUSES 1,554 449 374 1,259 262 374 1,726 467 1,050 1,586 126 315 297 261 260 1,419 499 252 12,530
Ad, adult; Ch, children; COPD, chronic obstructive pulmonary disease; Ne, neonate; PHMRC, Population Health Metrics Research Consortium; TB, tuberculosis; VA,
verbal autopsy.
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(<0.01%). Similarly for HIV/AIDS, in Bohol and Pemba
HIV/AIDS levels were very low (<0.01%), while in the
remaining sites the level was high (>1%). InterVA-4 gener-
ates from zero to three most likely causes per case, each
with an associated likelihood; cases with zero causes reflect
complete uncertainty. The sum of the likelihoods for each
case was always taken to be one in these analyses, includ-
ing, where necessary, an indeterminate cause component.
The WHO 2012 VA standard defines 62 cause of death
categories (including stillbirths) with corresponding Inter-
national Classification of Diseases, 10th revision (ICD-10)
codes. These differ in some respects from the PHMRC
cause categories, and for the purposes of comparison the
correspondence between the WHO and PHMRC categories
(34 cause version as previously published [7]) is shown in
Table 2. The concordance correlation coefficient between
cause-specific mortality fractions (CSMF) was calculated
using Stata, according to the method described by Lin [15].
A separate experiment was carried out using the DHS
2010 Afghanistan national mortality survey [16] database
as an independent source, to estimate the effect of losing
the missing PHMRC VA variables on the overall mortality
cause distribution as determined by InterVA-4. This in-
volved running InterVA-4 separately on a dataset extracted
from the DHS and then re-running with the non-PHMRC
indicators removed.
No specific ethical clearance was required for this study,
since it only used the public domain anonymized PHMRC
VA dataset, the public domain DHS 2010 Afghanistan
dataset and the public domain InterVA-4 model.
Results
From the overall 12,530 cases in the PHMRC VA dataset,
11,984 cases met the basic minimum requirements of the
WHO 2012 VA standard (valid age, sex and some symptom
data). Among these cases, 1,688 (14.1%) of the PHMRC
causes of death fell into categories described as ‘Other…’
which do not represent specific causes of death.
Deaths among women aged 12 to 49 accounted for
1,884/11,984 (15.7%) of the cases, and 458 (24.3%) of thesedeaths were classified as ‘Maternal’ in the PHMRC dataset.
However, 17/1,884 (0.9%) of these deaths had contradictory
pregnancy status information in the VA data (for example,
both pregnant and recently delivered at death). Of the 458
PHMRC ‘Maternal’ deaths, 90 (19.7%) were not reported in
the VA interview to have been pregnant at or within six
weeks of death. Hospital diagnoses reported 1,603 neonatal
deaths, 107 (6.7%) of which were said to be stillbirths in the
VA interviews. The remaining 1,496 neonatal deaths are
presented by cause and time in Figure 1. In 147/1,001
(14.7%) deaths which were recorded as stillbirths in hospi-
tals, the circumstances were recorded as neonatal deaths in
VA interviews, mostly during the first day of life. However,
the symptoms reported in many of these discrepant cases
were contradictory, leading to many being categorized as
indeterminate in cause by InterVA-4.
A high proportion of cases (7,898/11,984; 65.9%) were
reported as having respiratory symptoms in the VA inter-
views, although 2,134/11,984 (17.8%) had respiratory-related
PHMRC causes of death assigned. Table 3 shows the pro-
portions of cases reporting various respiratory symptoms
for respiratory-related PHMRC causes (2,134/11,984; 17.8%;
comprising asthma, birth asphyxia, COPD, lung cancer,
pneumonia, TB) and for other PHMRC causes of death.
CSMFs are shown in Table 4 by age group and for all
ages combined for 43 cause-of-death categories as deter-
mined by InterVA-4 and PHMRC. Differences in CSMF
and 95% confidence intervals (CIs) of those differences are
shown for the all-age CSMFs. For 22/43 causes (51.1%),
CSMF differences were less than 1%. Figure 2 illustrates
the correlation between PHMRC and InterVA-4 CSMFs
in the 11,984 cases and 43 cause categories analyzed. The
concordance correlation coefficient was 0.612 (95% CI 0.454
to 0.770). Excluding the residual categories, the concord-
ance correlation coefficient increased to 0.665 (95% CI
0.502 to 0.827).
In an empirical comparison of the DHS 2010 Afghanistan
dataset (3,349 deaths) run through InterVA-4 with and
without the input indicators not available in the PHMRC
dataset, overall 16.2% of causes of death were re-assigned
due to the missing indicators. There was a net shift of
Table 2 Working equivalence between WHO 2012 and
PHMRC cause of death categories
WHO 2012 VA cause categories PHMRC cause categories
01.01 Sepsis (non-obstetric) Sepsis
01.02 Acute resp infect incl
pneumonia
Pneumonia
01.03 HIV/AIDS related death AIDS
01.04 Diarrhoeal diseases Diarrhea/dysentery
01.05 Malaria Malaria
01.06 Measles Measles
01.07 Meningitis and encephalitis Meningitis; encephalitis
01.08 & 10.05 Tetanus Other infectious diseases
01.09 Pulmonary tuberculosis TB
01.10 Pertussis Other infectious diseases
01.11 Haemorrhagic fever Hemorrhagic fever
01.99 Other and unspecified infect dis Other infectious diseases
02.01 Oral neoplasms Other cancers
02.02 Digestive neoplasms Esophageal cancer; stomach
cancer
02.03 Respiratory neoplasms Lung cancer
02.04 Breast neoplasms Breast cancer
02.05 & 02.06 Reproductive
neoplasms M/F
Cervical cancer; prostate cancer




03.01 Severe anaemia Other non-communicable
diseases
03.02 Severe malnutrition Other non-communicable
diseases
03.03 Diabetes mellitus Diabetes
04.01 Acute cardiac disease Acute myocardial infarction
04.02 Stroke Stroke
04.03 Sickle cell with crisis Other non-communicable
diseases







06.01 Acute abdomen Other digestive diseases; other
non-communicable diseases
06.02 Liver cirrhosis Liver cirrhosis
07.01 Renal failure Renal failure
08.01 Epilepsy Epilepsy
98 Other and unspecified NCD Other digestive diseases; other
non-communicable diseases
10.06 Congenital malformation Congenital malformation
10.01 Prematurity Preterm delivery
10.02 Birth asphyxia Birth asphyxia
10.03 Neonatal pneumonia Pneumonia
Table 2 Working equivalence between WHO 2012 and
PHMRC cause of death categories (Continued)
10.04 Neonatal sepsis Meningitis/sepsis
10.99 Other and unspecified
neonatal CoD
n/a
11.01 Fresh stillbirth Stillbirth
11.02 Macerated stillbirth Stillbirth
12.01 Road traffic accident Road traffic
12.02 Other transport accident Other injuries
12.03 Accid fall Falls
12.04 Accid drowning and submersion Drowning
12.05 Accid expos to smoke
fire & flame
Fires
12.06 Contact with venomous
plant/animal
Bite of venomous animal
12.10 Exposure to force of nature Other injuries
12.07 Accid poisoning & noxious subs Poisonings
12.08 Intentional self-harm Suicide
12.09 Assault Homicide; violent death
12.99 Other and unspecified
external CoD
Other injuries
09.01 Ectopic pregnancy Maternal
09.02 Abortion-related death Maternal
09.03 Pregnancy-induced hypertension Maternal
09.04 Obstetric haemorrhage Maternal
09.05 Obstructed labour Maternal
09.06 Pregnancy-related sepsis Maternal
09.07 Anaemia of pregnancy Maternal
09.08 Ruptured uterus Maternal
09.99 Other and unspecified
maternal CoD
Maternal
99 Indeterminate Other defined causes of child
deaths
COPD, chronic obstructive pulmonary disease; PHMRC, Population Health
Metrics Research Consortium; TB, tuberculosis; VA, verbal autopsy.
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which increased most appreciably due to the missing indi-
cators included neonatal pneumonia, acute abdomen and
asthma, while the greatest decreases due to the missing in-
dicators were seen in birth asphyxia, COPD and diarrheal
diseases. However, the top six ranked causes of death were
the same in both cases.
Discussion
The PHMRC VA dataset undoubtedly represents an im-
portant attempt to collect a set of reference data for VA
that have corresponding causes of death established in
high-level facilities offering good diagnostic procedures.
Obviously, since the commencement of the PHMRC study















0 1 2-6 7-28
InterVA-4 PHMRC
days from birth days from birth
birth asphyxia prematurity infections
congenital other/unknown
Figure 1 Neonatal deaths by cause and time of death (n = 1,496) according to InterVA-4 and PHMRC cause of death assignments.
PHMRC, Population Health Metrics Research Consortium.
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presented here, equivalence between the PHMRC and
WHO 2012 VA cause of death categories and VA indicators
has been established as transparently and completely as
possible, given the inherent differences. Empirical findings
from the Afghan data comparison suggest that the WHO
2012 indicators which are missing from the PHMRC data-
set may have some effect in terms of decreased certainty
of cause attribution and redistribution of certain causes,
although the overall cause of death profile may not change
markedly in consequence. The relatively robust nature
of the InterVA model has also been demonstrated in a
previous sensitivity analysis [17].
Nevertheless, there are some differences both of principle
and detail that cannot be totally reconciled between the
PHMRC and WHO 2012 approaches. The PHMRC study
set out to rigorously define causes of death, but this in-
volved imposing some hierarchies which may not be
universally recognized and are not always consistent with
ICD-10 coding. For example, prematurity as cause of deathTable 3 Numbers (%) of verbal autopsy interviews reporting
PHMRC causes of death, by age group





Any breathing problem 7,898 945 (88.0%) 465 (89.6%)
Rapid breathing 4,126 578 (53.8%) 320 (61.7%)
Breathless on exertion 415 96 (8.9%)
Breathless lying down 1,965 322 (30.0%)
Chest indrawing 987 270 (52.0%)
Wheezing or grunting 2,188 323 (30.0%) 240 (46.2%)
aIncludes asthma, birth asphyxia, chronic obstructive pulmonary disease, lung cancer, pnecan be applied according to the PHMRC definitions if a
baby is born at <33 weeks gestational age and experienced
‘death from another medically documented neonatal
condition’ irrespective of that condition [7]. This differs
appreciably from ICD-10 coding: ‘The mode of death, e.g.
heart failure, asphyxia or anoxia, should not be entered…
[as the most important cause] …unless it was the only
fetal or infant condition known. This also holds true for
prematurity’. [18]. As can be seen from the PHMRC causes
of death in Figure 1, prematurity is consequently the dom-
inant component of mortality throughout the neonatal
period. InterVA-4, on the other hand, ascribes more of
these later neonatal deaths among premature babies to
infectious causes, based on their subsequently reported
symptoms. Neither of these two approaches is necessarily
right or wrong, and both may actually be different views
of the same reality; but the differences are very important
in statistical descriptions of neonatal mortality and in
assessing the comparability of different methods of cause
of death ascertainment.respiratory symptoms for respiratory-related and other









435 (80.4%) 4,260 (67.2%) 906 (62.5%) 887 (43.0%)
122 (22.6%) 2,312 (36.5%) 511 (35.3%) 283 (13.7%)
319 (5.0%)
1,643 (25.9%)
101 (18.7%) 349 (24.1%) 267 (12.9%)
60 (11.1%) 1,018 (16.1%) 340 (23.5%) 207 (10.0%)
umonia and tuberculosis. PHMRC, Population Health Metrics Research Consortium.
Table 4 Cause-specific mortality fractions (%) for 11,984 deaths by age group and for all ages as determined by
InterVA-4 and PHMRC hospital causes of death
Cause of death category Adults Children Neonates Stillbirths All ages
InterVA PHMRC InterVA PHMRC InterVA PHMRC InterVA PHMRC InterVA PHMRC diff 95% CI
01.01 Sepsis (non-obstetric) 0.13 0.4 6.35 0.15 1.04 −0.89 −1.09 to −0.70
01.02 Acute resp infect,
incl pneumonia
14.97 7.07 43.78 26.37 16.45 8.70 7.74 6.91 to 8.58
01.03 HIV/AIDS related
death
6.57 6.44 6.34 0.91 5.11 4.13 0.97 0.44 to 1.51
01.04 Diarrheal diseases 0.17 2.98 3.78 12.7 0.73 3.93 −3.20 −3.58 to −2.82
01.05 Malaria 1.8 1.23 11.68 5.59 3.03 1.68 1.35 0.97 to 1.74
01.06 Measles 0.03 0.64 1.17 0.12 0.19 −0.07 −0.17 to 0.03
01.07 Meningitis and
encephalitis
0.76 1.73 4.93 0.82 0.81 0.01 −0.22 to 0.23
01.09 Pulmonary
tuberculosis
5.64 3.33 0.24 3.53 2.06 1.47 1.05 to 1.89
01.11 Hemorrhagic fever 0.27 2.54 0.04 0.42 −0.37 −0.49 to −0.25
01.99 Other and unspecified
infect dis
1.89 3.35 1.33 3.4 1.39 2.63 −1.24 −1.60 to −0.89
02.02 Digestive neoplasms 3.2 2.51 1.98 1.55 0.43 0.09 to 0.76
02.03 Respiratory neoplasms 0.94 1.38 0.58 0.85 −0.27 −0.48 to −0.06
02.04 Breast neoplasms 1.59 2.54 0.99 1.57 −0.58 −0.87 to −0.30
02.05, 02.06 Reproductive
neoplasms M,F
2.55 2.54 1.58 1.57 0.01 −0.31 to 0.32
02.99 Other and unspecified
neoplasms
1.78 1.98 1.37 1.10 1.45 −0.35 −0.63 to −0.07
03.03 Diabetes mellitus 1.88 5.19 0.03 1.17 3.21 −2.05 −2.41 to −1.68
04.01 Acute cardiac disease 1.55 5.06 0.96 3.13 −2.17 −2.52 to −1.81
04.02 Stroke 4.93 7.8 3.05 4.82 −1.77 −2.27 to −1.28
04.99 Other and unspecified
cardiac dis
12.75 5.38 0.03 3.81 7.89 3.96 3.94 3.34 to 4.53
05.01 Chronic obstructive
pulmonary dis
1.87 2.15 1.16 1.33 −0.17 −0.45 to 0.11
05.02 Asthma 1.5 0.57 0.22 0.96 0.35 0.61 0.41 to 0.81
06.02 Liver cirrhosis 1.33 3.93 0.82 2.43 −1.61 −1.92 to −1.29
07.01 Renal failure 0.83 5.4 0.52 3.34 −2.82 −3.17 to −2.48
08.01 Epilepsy 0.87 0.59 0.37 0.60 0.37 0.23 0.06 to 0.41
98 Other and unspecified
NCD
12.13 7.61 5.59 2.34 8.42 5.09 3.33 2.69 to 3.96
09 Maternal CoD 2.57 6.22 1.59 3.85 −2.26 −2.67 to −1.85
10.01 Prematurity 7.99 40.8 0.85 1.14 5.46 −4.32 −4.77 to −3.87
10.02 Birth asphyxia 31.46 28.57 3.79 4.52 3.82 0.70 0.20 to 1.21
10.03 Neonatal pneumonia 38.47 5.18 0.54 5.19 0.69 4.50 4.08 to 4.92
10.04 Neonatal sepsis 5.03 10.23 0.18 0.63 1.37 −0.74 −0.99 to −0.49
10.06 Congenital
malformation
1.45 15.22 0.68 0.25 2.04 −1.78 −2.05 to −1.52
10.99 Other and unspecified
neonatal CoD
2.77 1.33 0.48 0.00 0.48 0.35 to 0.60
11 Stillbirth 5.62 76.94 100 7.18 8.35 −1.17 −1.85 to −0.50
12.01 Road traffic accident 1.51 2.6 3.68 4.57 1.54 2.36 −0.82 −1.17 to −0.47
12.03 Accid fall 0.7 2.17 1.41 2.18 0.66 1.70 −1.04 −1.31 to −0.77
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Table 4 Cause-specific mortality fractions (%) for 11,984 deaths by age group and for all ages as determined by
InterVA-4 and PHMRC hospital causes of death (Continued)
12.04 Accid drowning and
submersion
0.57 1.39 3.55 3.96 0.94 1.51 −0.57 −0.85 to −0.30
12.05 Accid expos to smoke,
fire & flame
0.37 1.59 1.54 3.25 0.48 1.52 −1.04 −1.29 to −0.79
12.06 Contact with
venomous plant/animal
0.55 0.84 2.31 2.59 0.72 0.94 −0.22 −0.45 to 0.01
12.07 Accid poisoning and
noxious subs
0.04 1.11 0.33 0.91 0.08 0.83 −0.75 −0.92 to −0.58
12.08 Intentional self-harm 2.01 1.61 0.03 1.25 0.99 0.26 −0.01 to 0.52
12.09 Assault 2.27 2.2 3.3 2.49 1.94 1.77 0.18 −0.17 to 0.52
12.99 Other and unspecified
external CoD
0.02 1.27 0.12 0.03 0.78 −0.75 −0.92 to −0.59
99 Indeterminate 7.71 7.31 8.54 7.21 15.69 8.24 1.40 6.84 6.31 to 7.38
CI, confidence interval; PHMRC, Population Health Metrics Research Consortium.
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not include any clinical details from the hospital work-ups
in addition to the assigned cause of death. It would add
considerable value to have basic clinical parameters for
these deaths irrespective of cause of death. As has been
shown in a multicenter analysis of VA cause of death
against HIV serostatus, being infected with HIV has
consequences for cause of death far beyond the number of
classic AIDS deaths [19], and this may also be true for
other factors routinely recorded as clinical parameters,
such as malaria parasitemia, hemoglobin levels, and so on.
It would also be of interest to have included the PHMRC
local physicians’ interpretation of the VAs in order to see





















Figure 2 Correlation between cause-specific mortality fractions as de
11,984 verbal autopsy cases in 43 cause categories. Outlying data poin
and shown against the line of equivalence. PHMRC, Population Health Metgroup previously concluded that physicians did not perform
particularly well against the hospital causes of death [20].
The very high proportion of VA interviews reporting
respiratory symptoms in the PHMRC dataset is also worth
noting. Table 3 shows rather non-specific relationships
between respiratory symptoms and respiratory causes of
death in the PHMRC data, which need further investigation
and explanation. One possibility is that many patients in
tertiary facilities may receive oxygen therapy in the final
stages of an illness leading to death, which may be inter-
preted as respiratory difficulties by family and friends when
later responding to a VA interview. In any case, the high
proportion of VAs reporting respiratory symptoms leads
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of treatment received in the final illness would add value
to the utility of the PHMRC dataset. By extension, this
and similar issues also raise questions of the validity of
using tertiary facility deaths as the evidence base for VA
methods. For example, since all the injury cases in the
PHMRC data were hospitalized, clearly none of them could
have been instantaneous or near-instantaneous fatalities.
On closer examination, many of the VAs for injury cases
also reported a range of symptoms not obviously associated
with their injuries by the time they died in hospital; but,
according to the PHMRC protocols, any ‘third-party
written account’ of an injury makes that injury the cause
of death, irrespective of further clinical details [7].
There are some significant omissions in the PHMRC
indicators compared with the WHO 2012 standard. Many
of the detailed items relating to obstetric causes of death
were missing from the PHMRC instrument, for example.
Other items were recorded more precisely by PHMRC,
such as details around loss of consciousness and tobacco
consumption. Inevitably the comparability of cause of death
between the PHMRC cause categories and the WHO 2012
VA cause categories generated by InterVA-4 are somewhat
compromised by the differences in cause definitions and by
missing 30% of the WHO 2012 VA indicators. Given these
sources of variation, the overall concordance correlation
coefficient of 0.6, as reflected in Figure 2 for specific cause
categories, reflected reasonably good agreement. Some
particular cause categories, such as pneumonia, some
neonatal causes and certain residual groupings, accounted
for much of the non-concordance.
Unsurprisingly, there were cases within the PHMRC
database which showed blatant inconsistencies between
hospital cause of death and responses to some VA ques-
tions. The most obvious were the 147 cases recorded as
stillbirths in hospital but which were described as neonatal
deaths in VA interviews, and the 90 hospital maternal
deaths described as neither pregnant nor recently delivered
in VA interviews. There is no way of knowing from the
dataset whether these reflected data quality issues either in
the hospital causes of death or VA material, or whether VA
respondents were actually, either knowingly or unwittingly,
presenting a different picture. It is, of course, likely that
there were similar phenomena relating to other parameters
which cannot be so easily checked. However, it raises an
important issue if such a dataset is to be used to build an
evidence-based model for VA interpretation, because any
data-driven model based solely on these data would ‘learn’,
for example, that a proportion of stillbirths show signs of
life and that a proportion of maternal deaths occur in
non-pregnant women. These effects are of particular
concern in the case of, for example, the random forest
and tariff models which the PHMRC group has built
exclusively from this dataset and then evaluated using thesame data [2,3]. Earlier work with artificial neural networks
showed that VA models could be built with extremely high
internal validity but had very limited external validity [21].
PHMRC’s earlier conclusions that independent methods
(physician interpretation [20] and InterVA-3 [22]) performed
less well against the PHMRC dataset than their internally-
derived methods essentially confirm that the internal and
external validities of automated VA methods can be very
different. These findings are also reflected in a systematic
review of automated VA methods [23]. There may be an
argument for an expert panel to censor unreliable or
contradictory cases from any VA reference database before
using it to build VA models, in order to improve external
validity. In addition, including residual cause of death
categories in data for building models is unlikely to be
very productive, given that residual categories are likely to
include multifarious symptomatology, with no clear map-
ping between symptoms and cause of death categories.
Conclusions
The PHMRC VA dataset is a unique resource in terms
of offering mappings from causes of death determined in
tertiary hospitals to corresponding VA data. The dataset
would be all the more valuable if it included clinical
diagnostic data, details of hospital treatment and local
physicians’ interpretation of the VA material. In addition,
a more usable presentation of terms included in the VA
narratives might add further insights.
Such a dataset basically has two potential uses in relation
to VA methods in general. Firstly, it is potentially a source
of reference VA data which can be used to evaluate various
approaches intended for interpreting other VA material,
basically as done here in Figure 2. When used in that way,
it should not be applied to data-driven models that have
themselves been built from this same reference dataset to
avoid confusion between the internal and external validity
of models. Secondly, it is potentially a source of evidence
between established causes of death and VA data that can
be used to build evidence-based models for interpreting
other VA data. Used in this context, it would be important
to censor obviously misleading cases and probably also
to exclude residual cause of death categories before extract-
ing evidence from the dataset into models. In both uses, it
is impossible to completely discount the effect of taking
only tertiary hospital cases and cause of death assignments,
which clearly differ in some important respects from more
usual all-population applications of VA. Nevertheless, this
effect has to be weighed against the advantages of having
hospital causes of death based on sound clinical evidence.
It would still be very interesting to see studies of all-
population post-mortem series from settings in low- and
middle-income countries in order to build a more defini-
tive evidence base from which to construct and validate
VA methods [24].
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